Dimethylformamide → N1-(3-bromoimidazo[1,2-b]pyridazin-6-yl)-N3-methyl-N3-phenylpropane-1,3-diamine

HRID 870654Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 870654
[Br:1][C:2]1[N:6]2[N:7]=[C:8](F)[CH:9]=[CH:10][C:5]2=[N:4][CH:3]=1.[CH3:12][N:13]([C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1)[CH2:14][CH2:15][CH2:16][NH2:17].CN(C=O)C>CCOC(C)=O.O>[Br:1][C:2]1[N:6]2[N:7]=[C:8]([NH:17][CH2:16][CH2:15][CH2:14][N:13]([CH3:12])[C:18]3[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=3)[CH:9]=[CH:10][C:5]2=[N:4][CH:3]=1

Komponenten

6

Versuchsvorschrift

To 300 mg (1.389 mmol) of the 3-bromo-6-fluoroimidazo[1,2-b]pyridazine, was added N1-methyl-N1-phenylpropane-1,3-diamine (456 mg, 2.778 mmol) Cs2CO3 (903 mg, 2.778 mmol) and 10 mL DMF. This mixture is stirred overnight at rt. It was diluted with 30 mL EtOAc, and 15 mL of water. The organic layer was washed with brine and dried over MgSO4. It was concentrated and purified using silica gel chromatography (ISCO) eluting with 0-10% MeOH/DCM to obtain 301 mg (60%) of product.

Aufarbeitung

  1. washThe organic layer was washed with brine
  2. dry with materialdried over MgSO4
  3. concentrationIt was concentrated
  4. custompurified
  5. washeluting with 0-10% MeOH/DCM

Quellen und Nachweise

ORD-Eintrag
ord-2d1311ab99bf4b158a2913fc2252087b
Quelldatensatz
uspto-grants-2015_03
Patentnummer
US08969565B2

Notizen zur Reaktion

Wird geladen…